1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and selegiline

1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with selegiline in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirobe, M; Kotake, Y; Ohta, S; Tasaki, Y	1
Carlson, EC; Ebadi, M; Shavali, S; Swinscoe, JC	1

Other Studies

2 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and selegiline

Article	Year
Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies. Brain research, 1998, Mar-23, Volume: 787, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Brain Chemistry; Chromatography, Gas; Depression, Chemical; In Vitro Techniques; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Phenethylamines; Selegiline; Tetrahydroisoquinolines	1998
1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells. Journal of neuroscience research, 2004, May-15, Volume: 76, Issue:4 Topics: Adenosine Triphosphate; alpha-Synuclein; Antioxidants; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Coenzymes; Cysteine Proteinase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glutathione; Humans; Immunohistochemistry; Microscopy, Electron; Nerve Tissue Proteins; Neuroblastoma; Neuroprotective Agents; Oligopeptides; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selegiline; Synucleins; Tetrahydroisoquinolines; Time Factors; Ubiquinone	2004

Article

Year

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies.

Brain research, 1998, Mar-23, Volume: 787, Issue:2

Topics: Animals; Anti-Arrhythmia Agents; Brain Chemistry; Chromatography, Gas; Depression, Chemical; In Vitro Techniques; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Phenethylamines; Selegiline; Tetrahydroisoquinolines

1998

1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.

Journal of neuroscience research, 2004, May-15, Volume: 76, Issue:4

Topics: Adenosine Triphosphate; alpha-Synuclein; Antioxidants; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Coenzymes; Cysteine Proteinase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Glutathione; Humans; Immunohistochemistry; Microscopy, Electron; Nerve Tissue Proteins; Neuroblastoma; Neuroprotective Agents; Oligopeptides; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selegiline; Synucleins; Tetrahydroisoquinolines; Time Factors; Ubiquinone

2004